Mlp Saglik Hizmetleri As Class B · BIST:MPARK

Mlp Saglik Hizmetleri As Class B — MLP Care — Q1 2022 Earnings Presentation

23 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, May 11, 2022

  1. Slide 1: MLPCARE Q1 2022 Presentation

    MLPCARE Q1 2022 PRESENTATION M AY 11 t h , 2 0 2 2

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava

  3. Slide 3: Muharrem Usta, Chairman & CEO

    MUHARREM USTA CHAIRMAN & CEO

  4. Slide 4: At a Glance: MLP Care Q1 2022 Financial Highlights

    At a Glance: MLP Care Q1 2022 Financial Highlights  Strong growth in all revenue groups Revenue EBITDA  EBITDA improved mainly due to TL 2,187 m TL 501 m 81% Growth 72% Growth  strong operational performance Q1 2021: Q1 2021:  effective cost saving measures TL 1,211 m TL 291 m  Reduced leverage

  5. Slide 5: # of People Top-up Insurance Users Exceeds 2.6 m

    # of People Top-up Insurance Users Exceeds 2.6 m # of People with Insurance in Turkey (in thousand) 2,504 2,633 5,138 2,327 1,791 4,118 Growth (Q1 2022 – Q1 2021) 7.6% 47.0% 24.8% PMI Top-up PMI+Top-up # of People with Top-up Insurance in Turkey (in thousand) 3.2022; 2,633 3.2021; 1,791 Average LTM

  6. Slide 6: FMT Revenue triples in TL terms

    FMT Revenue tripples in TL terms Medical Tourism Revenue (USD m) TOP 10 FMT Revenue % by Department in Q1 2022 57.6% 23 13% 11% 10% 10% 15 6% 5% 3% 3% 3% 3% Hematology Hematology Orthopedics Cardiovascular Oncology Oncology Cardiology General Surgery Brain and Neuro Plastic Surgery Radiation Medical

  7. Slide 7: We accelerate our sustainability efforts

    We accelerate our sustainability efforts Completed Planned  Sustainability Working Group To Be More Comprehensive  Sustainability trainings for employees  Stakeholders’ views for materiality analysis  Materiality matrix  Detailed carbon footprint calculation  Data collection  Review of supply

  8. Slide 8: Burcu Öztürk, CFO

  9. Slide 9: Revenue grows above inflation

    Revenue grows above inflation Revenue (TLm) 80.5% 2,187 1,211 Q1 2021 Q1 2022 Denotes growth of Revenue vs. the same period of the last year 9

  10. Slide 10: All payer types continue to grow

    All payer types continue to grow Q1 2022 166%  Revenue from SSI was up by 42% in Q1 2022 4% (SSI Insurance allows for a wide addressable market, 198% which is c.98% of the total population) 21% 42% 15%  Self pay was up by 53% in Q1 2022  Revenue from PMI, Top-up & Contracted Institutions was up b

  11. Slide 11: All revenue segments continue to grow

    All revenue segments continue to grow Domestic Patient Medical Tourism Ancillary Business Revenue Revenue 65.8% 197.7% 165.5% 1,771 91 325 1,068 34 109 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Domestic Revenue q-o-q Growth Accelerated Growth of Foreign Increase in Managed Hospitals’ Continued

  12. Slide 12: Average Prices are supported by SSI tariff revisions

    Average Prices are supported by SSI tariff revisions Outpatient Revenues (TLm) Inpatient Revenues (TLm) 78.4% 57.3% 54.5% 21.5% 24.0% 35.7% 235 137 227 103 770 1,000 432 636 Q1 2021 Volume & Mix Price Q1 2022 Q1 2021 Volume & Mix Price Q1 2022 Average Revenue Per Visit (ARPV) Average Revenue Per Pro

  13. Slide 13: EBITDA is up by 72%

    EBITDA is up by 72% 1 EBITDA (TLm) 71.9% 501 291 1 Q1 2021 Q1 2022 1 1 EBITDA and EBITDA margin calculated by deducting general administrative expenses from gross profit and adding depreciation and amortization expenses Denotes growth of EBITDA vs. the same period of the last year 13

  14. Slide 14: Prudent Cost Management

    Prudent Cost Management Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 24.0% 22.9%  Material costs as a % of revenue decreased in Q1 2022 due to effective inventory management 0.9% 0.9%  Doctor costs as a % of

  15. Slide 15: Bottom line improves on the back of strong operations

    Bottom line improves on the back of strong operations Net Profit (TLm) Net Profit (TLm) Allocated to Equity Holders of the Parent 159.0% 150.3% 200 170 80 66 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Denotes growth of Net Profit and Net Profit Allocated to Equity Holders of the Parent vs. the same period of t

  16. Slide 16: Leverage Ratios continue to decline

    Leverage Ratios continue to decline 2,500 4.0 Net Debt (TLm) 3.5 2,000 2,116 2,069 1,984 3.0 1,500 1,521 2.5 1,000 2.2x Reduction 345mTL 1,176 1,019 2.0 Reduction 157mTL 500 1.5x 1.5 1.3x - 1.0 2020 2021 Q1 2022 Net Debt (exc. IFRS 16) Net Debt (inc. IFRS 16) Net Debt/EBITDA  FX risk of balance she

  17. Slide 17: Strong Cash Generation

    Strong Cash Generation Maintenance Capex (TLm) Total Capex (TLm) OCF/ EBITDA FCF/ EBITDA 54.7% 50.8% 72.6% 2.8% 4.8% 71.4% 2.0% 363 254 61 3.6% 105 159 208 24 43 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 % of Revenue % of Revenue % of EBITDA % of EBITDA 17

  18. Slide 18: Q&A

    Q&A

  19. Slide 19: Closing Remarks

    Closing Remarks MUHARREM USTA CHAIRMAN & CEO

  20. Slide 20: Thank You!

    Thank You! MLP Care Investor Relations Deniz Can Yücel +90 212 227 5555 (Ext: 1148) deniz.yucel@mlpcare.com http://investor.mlpcare.com/en/

  21. Slide 21: Historical Balance Sheet

    Historical Balance Sheet Unaudited Audited TLm March 31, 2022 December 31, 2021 Cash and cash equivalents 650 680 Trade receivables 1,634 1,318 Inventory 342 285 Short term other assets 476 458 Current assets 3,102 2,741 Tangible and intangible fixed assets 1,757 1,716 Right of use assets 606 539 De

  22. Slide 22: Historical P&L Statements

    Historical P&L Statements Unaudited Unaudited TLm Q1 2022 Q1 2021 Change (%) Revenues 2,187 1,211 80.5% Cost of service (-) (1,596) (908) 75.7% Gross profit 591 303 94.9% General administration expenses (-) (198) (85) 133.3% Other income from operations 137 85 61.4% Other expenses from operations (-

  23. Slide 23: EBITDA Reconciliation

    EBITDA Reconciliation TLm Q1 2022 Q1 2021 Change (%) Revenue 2,187 1,211 80.5% Cost of service (1,596) (908) 75,7% Gross profit 591 303 94.9% General administrative expenses (-) (198) (85) 133.3% Depreciation and amortization expenses (Cost of service) 101 68 48.1% Depreciation and amortization expe

MLP Care — Q1 2022 Earnings Presentation on 6ix